Google Übersetzer
Kymera Therapeutics, Inc.
About
Kymera Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 30 2026
Kymera Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update
Apr 23 2026
Kymera Therapeutics to Report First Quarter 2026 Financial Results on April 30, 2026
Apr 13 2026
Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral STAT6 Degrader for the Treatment of Moderate to Severe Asthma
Apr 9 2026
Kymera Therapeutics Announces Gilead Sciences’ Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate
Mar 28 2026
Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting
Recent Videos
KYMR, Kymera Therapeutics, Inc. stock prices historical data
Apr 19, 2026
09 April 26. Biotech Stock News. Daily Recap #English #Shorts $XBI #trading #biotechnews #dailynews
Apr 09, 2026
09 abril 26. Noticias acciones biotecnológicas. Resumen diario. #Español #Shorts #diario $XBI #bio
Apr 09, 2026
Kymera Therapeutics Q4 2025 Earnings Call
Feb 27, 2026